Identification of robust predictors for ibrutinib response by multiomics in MYD88-mutated Waldenström macroglobulinemia

被引：2

作者：

Richardson, Kris ^{[1
,2
]}

Castillo, Jorge J. ^{[1
,2
]}

Sarosiek, Shayna R. ^{[1
,2
]}

Branagan, Andrew R. ^{[2
,3
]}

Flynn, Catherine A. ^{[1
]}

Meid, Kirsten ^{[1
]}

Gustine, Joshua N. ^{[2
,3
]}

Liu, Xia ^{[1
,2
]}

Kofides, Amanda ^{[1
]}

Liu, Shirong ^{[1
,2
]}

Wolf, Julie L. ^{[4
]}

Kacena, Katherine A. ^{[5
]}

Patterson, Christopher J. ^{[1
]}

Guerrera, Maria Luisa ^{[1
,2
]}

Tsakmaklis, Nicholas ^{[1
]}

Treon, Steven P. ^{[1
,2
]}

Hunter, Zachary R. ^{[1
,2
]}

机构：

[1] Dana Farber Canc Inst, Bing Ctr Waldenstroms Macroglobulinemia, SM630,450 Brookline Ave, Boston, MA 02115 USA

[2] Harvard Med Sch, Dept Med, Boston, MA USA

[3] Massachusetts Gen Hosp, MGH Canc Ctr, Boston, MA USA

[4] Wolf Biostat, Boston, MA USA

[5] BioBridges, Boston, MA USA

来源：

BLOOD ADVANCES | 2024年 / 8卷 / 09期

基金：

美国国家卫生研究院;

关键词：

WALDENSTROM MACROGLOBULINEMIA; RESISTANCE; MUTATIONS; SURVIVAL; MYD88; ZANUBRUTINIB; DETERMINANT; ERK1/2; CELLS;

D O I：

10.1182/bloodadvances.2023012111

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：2133 / 2137

页数：5

共 24 条

[11]

Guerrera ML, 2023, Aberrant Expression of Spliced WNK2 Is an Early Event in MYD88 Mutated WM That Activates ERK1/2 and Supports Tumor Growth,, V142, P3303

[12] Bone marrow involvement and subclonal diversity impairs detection of mutated CXCR4 by diagnostic next-generation sequencing in Waldenstrom macroglobulinaemia [J].

Gustine, Joshua N. ;

Xu, Lian ;

Yang, Guang ;

Liu, Xia ;

Kofides, Amanda ;

Tsakmaklis, Nicholas ;

Munshi, Manit ;

Demos, Maria ;

Guerrera, Maria L. ;

Meid, Kirsten ;

Patterson, Christopher J. ;

Sarosiek, Shayna ;

Branagan, Andrew R. ;

Hunter, Zachary R. ;

Castillo, Jorge J. ;

Treon, Steven P. .

BRITISH JOURNAL OF HAEMATOLOGY, 2021, 194 (04) :730-733

[13] CXCR4S338X clonality is an important determinant of ibrutinib outcomes in patients with Waldenstrom macroglobulinemia [J].

Gustine, Joshua N. ;

Xu, Lian ;

Tsakmaklis, Nicholas ;

Demos, Maria G. ;

Kofides, Amanda ;

Chen, Jiaji G. ;

Liu, Xia ;

Munshi, Manit ;

Guerrera, Maria Luisa ;

Chan, Gloria G. ;

Patterson, Christopher J. ;

Keezer, Andrew ;

Meid, Kirsten ;

Dubeau, Toni ;

Yang, Guang ;

Hunter, Zachary R. ;

Treont, Steven P. ;

Castillo, Jorge J. .

BLOOD ADVANCES, 2019, 3 (19) :2800-2803

[14] The genomic landscape of Waldenstrom macroglobulinemia is characterized by highly recurring MYD88 and WHIM-like CXCR4 mutations, and small somatic deletions associated with B-cell lymphomagenesis [J].

Hunter, Zachary R. ;

Xu, Lian ;

Yang, Guang ;

Zhou, Yangsheng ;

Liu, Xia ;

Cao, Yang ;

Manning, Robert J. ;

Tripsas, Christina ;

Patterson, Christopher J. ;

Sheehy, Patricia ;

Treon, Steven P. .

BLOOD, 2014, 123 (11) :1637-1646

[15] Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 [J].

Love, Michael I. ;

Huber, Wolfgang ;

Anders, Simon .

GENOME BIOLOGY, 2014, 15 (12)

[16] PRDM15 safeguards naive pluripotency by transcriptionally regulating WNT and MAPK-ERK signaling [J].

Mzoughi, Slim ;

Zhang, Jingxian ;

Hequet, Delphine ;

Teo, Shun Xie ;

Fang, Haitong ;

Xing, Qiao Rui ;

Bezzi, Marco ;

Seah, Michelle Kay Yi ;

Ong, Sheena L. M. ;

Shin, Eun Myoung ;

Wollmann, Heike ;

Wong, Esther S. M. ;

Al-Haddawi, Muthafar ;

Stewart, Colin L. ;

Tergaonkar, Vinay ;

Loh, Yuin-Han ;

Dunn, N. Ray ;

Messerschmidt, Daniel M. ;

Guccione, Ernesto .

NATURE GENETICS, 2017, 49 (09) :1354-+

[17] Dual-specificity phosphatases: critical regulators with diverse cellular targets [J].

Patterson, Kate I. ;

Brummer, Tilman ;

O'Brien, Philippa M. ;

Daly, Roger J. .

BIOCHEMICAL JOURNAL, 2009, 418 :475-489

[18] Biomarker analysis of the ASPEN study comparing zanubrutinib with ibrutinib for patients with Waldenström macroglobulinemia [J].

Tam, Constantine S. ;

Opat, Stephen ;

D'Sa, Shirley ;

Jurczak, Wojciech ;

Lee, Hui-Peng ;

Cull, Gavin ;

Owen, Roger G. ;

Marlton, Paula ;

Wahlin, Bjoern E. ;

Garcia-Sanz, Ramon ;

McCarthy, Helen ;

Mulligan, Stephen ;

Tedeschi, Alessandra ;

Castillo, Jorge J. ;

Czyz, Jaros law ;

De Larrea, Carlos Fernandez ;

Belada, David ;

Libby, Edward ;

Matous, Jeffrey ;

Motta, Marina ;

Siddiqi, Tanya ;

Tani, Monica ;

Trneny, Marek ;

Minnema, Monique C. ;

Buske, Christian ;

Leblond, Veronique ;

Treon, Steven P. ;

Trotman, Judith ;

Wu, Binghao ;

Yu, Yiling ;

Shen, Zhirong ;

Chan, Wai Y. ;

Schneider, Jingjing ;

Allewelt, Heather ;

Cohen, Aileen ;

Dimopoulos, Meletios A. .

BLOOD ADVANCES, 2024, 8 (07) :1639-1650

[19] Long-Term Follow-Up of Ibrutinib Monotherapy in Symptomatic, Previously Treated Patients With Waldenstrom Macroglobulinemia [J].

Treon, Steven P. ;

Meid, Kirsten ;

Gustine, Joshua ;

Yang, Guang ;

Xu, Lian ;

Liu, Xia ;

Patterson, Christopher J. ;

Hunter, Zachary R. ;

Branagan, Andrew R. ;

Laubach, Jacob P. ;

Ghobrial, Irene M. ;

Palomba, M. Lia ;

Advani, Ranjana ;

Castillo, Jorge J. .

JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06) :565-+

[20] Single-Agent Ibrutinib for Rituximab-Refractory Waldenstrom Macroglobulinemia: Final Analysis of the Substudy of the Phase III Innovate™ Trial [J].

Trotman, Judith ;

Buske, Christian ;

Tedeschi, Alessandra ;

Matous, Jeffrey V. ;

MacDonald, David ;

Tam, Constantine S. ;

Tournilhac, Olivier ;

Ma, Shuo ;

Treon, Steven P. ;

Oriol, Albert ;

Ping, Jerry ;

Briso, Eva M. ;

Arango-Hisijara, Israel ;

Dimopoulos, Meletios A. .

CLINICAL CANCER RESEARCH, 2021, 27 (21) :5793-5800

← 1 2 3 →